Interestingly, a marked difference was apparent especially at relatively earlier pseudotime points for C3.DN-Tem-CO , as evidenced by a substantially higher fraction of cells in patients than in healthy individuals (Fig. 3a , gray box).
← all excerpts
Progressive accumulation of circulating CD27<sup>-</sup>CD28<sup>-</sup> effector/memory CD8<sup>+</sup> T cells in patients with lung cancer blunts responses to immune checkpoint inhibitor therapy.
1
—
—